ERIVEDGE (Genentech, Inc.)
Welcome to the PulseAid listing for the ERIVEDGE drug offered from Genentech, Inc.. This Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genentech, Inc. |
NON-PROPRIETARY NAME: | vismodegib |
SUBSTANCE NAME: | VISMODEGIB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-01-30 |
END MARKETING DATE: | 0000-00-00 |
ERIVEDGE HUMAN PRESCRIPTION DRUG Details:
Item Description | ERIVEDGE from Genentech, Inc. |
LABELER NAME: | Genentech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2012-01-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50242-140_ae126691-df0d-4ac6-bc56-5a3566d1f225 |
PRODUCT NDC: | 50242-140 |
APPLICATION NUMBER: | NDA203388 |
Other VISMODEGIB Pharmaceutical Manufacturers / Labelers: